Rephonic
Artwork for Oncology On The Go

Oncology On The Go

CancerNetwork
Immunotherapy
Lymphoma
Kidney Cancer
Liquid Biopsy
Renal Cell Carcinoma
Sarcomatoid Differentiation
Targeted Therapies
Cytokine Release Syndrome
Gender Disparities In Medicine
Work-Life Balance In Healthcare
CAR T-Cell Therapy
Mentorship In Oncology
Phase 1B Study
Overall Survival Outcomes
Cancer Vaccines
FDA
Multiple Myeloma
Captem
Glioblastoma
Follicular Lymphoma

Oncology On The Go is a weekly podcast that talks to authors and experts to thoroughly examine featured articles in the journal ONCOLOGY and review other challenging treatment scenarios in the cancer field from a multidisciplinary perspective. Our discussions also offer timely insight into topics ranging from recent FDA approvals to relevant research presented at major oncology conferences. As th... more

PublishesWeeklyEpisodes233Founded6 years ago
Number of ListenersCategory
Science

Listen to this Podcast

Artwork for Oncology On The Go

Latest Episodes

In a conversation with CancerNetwork®, Julian Hong, MD, MS, discussed considerations for optimizing care among patients with mental health disorders (MHDs) who are undergoing treatment for cancer. He spoke in the context of a study he and coauthors p... more

In this episode of Oncology on The Go, created in collaboration with the American Psychosocial Oncology Society, Daniel C. McFarland, DO, and Ilana M. Braun, MD, dove into the complexities of cannabis use within the oncology landscape. They explored ... more

During a visit to Columbia University Irving Cancer Research Center, experts across hematologic oncology shared their perspectives on key trends and developments in their respective fields. These conversations explored novel therapeutic approaches an... more

In a conversation with CancerNetwork®, Sagar Lonial, MD, FACP, FASCO, discussed the potential implications of the FDA approving iberdomide plus daratumumab (Darzalex) and dexamethasone for patients with relapsed/refractory multiple myeloma. He spoke ... more

Daniel C. McFarland, DO, and Boris Kiselev, MD, highlighted the need for oncologists to recognize and address depression for patients with cancer.

In a new episode of Oncology on the Go created in collaboration with the American Psychosocial Oncolo... more

Sarah Poland, MD, lead author of a recently published article in the journal ONCOLOGY titled Advances in Immunotherapy for Breast Cancer, highlighted key findings from her review in a conversation with CancerNetwork®.1 Throughout the discussion, she ... more

At the 2026 Tandem Meetings, CancerNetwork® spoke with a variety of experts who presented on key developments and advancements across hematologic oncology. As part of different oral presentations and poster sessions, researchers and clinicians shared... more

In a conversation with CancerNetwork®, Manoj Bhasin, PhD, MS, spoke about findings from a study in which he and colleagues developed a single-cell atlas characterizing the dysregulation of the bone marrow immune microenvironment in newly diagnosed mu... more

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

Two Onc Docs
Two Onc DocsSam and Karine
OncLive® On Air
OncLive® On AirOncLive® On Air
ASCO Guidelines
ASCO GuidelinesAmerican Society of Clinical Oncology (ASCO)

Recent Guests

Dr. Julian Hong
A UCSF oncologist discussing strategies for improving screening and care for cancer patients with mental health disorders
University of California, San Francisco
Episode: S1 Ep207: Providing Support for Mental Health Disorders Across Cancer Populations
Ilana Braun
Clinician and researcher discussing cannabis in oncology
Episode: S1 Ep206: Is It Helping or Harming? A Clinician’s Guide to Cannabis Use in Oncology
Nicole Lamanna
Columbia University physician-scientist highlighted FDA approval and trial data for CLL treatment strategies
Columbia University Irving Cancer Research Center
Episode: S1 Ep205: Insights Across Hematologic Oncology at Columbia University
Rajshekhar Chakraborty
Physician discussing bispecific antibodies in multiple myeloma and community adoption
Not explicitly stated in transcript (colleague in hematologic oncology)
Episode: S1 Ep205: Insights Across Hematologic Oncology at Columbia University
Hua-Jay Jeff Cherng
Researcher focusing on translational work with CTDNA and MRD in lymphoma and DLBCL
Academic research on lymphoma biomarkers
Episode: S1 Ep205: Insights Across Hematologic Oncology at Columbia University
Dr. Sagar Lonial
From Emory University School of Medicine and Winship Cancer Institute of Emory University
Emory University
Episode: S1 Ep204: Unraveling the Potential of Iberdomide and CELMoDs in Multiple Myeloma
Daniel C. McFarland
Hem/Onc physician with psychiatry training, discussed diagnostic criteria and clinical nuances
Episode: S1 Ep203: Navigating Depression in Cancer Care
Boris Kiselev
Psychiatrist contributing expertise on depression in oncology settings
Episode: S1 Ep203: Navigating Depression in Cancer Care
Dr. Ram Prakash Thirugnanasambandam
Expert from the University of Miami specializing in AI applications in oncology
University of Miami
Episode: S1 Ep199: How to Responsibly Use AI in Palliative Care and Hematologic Malignancies

Host

Russ Conroy
Host of Oncology On The Go podcast

Top Science Podcasts

Something You Should Know
Something You Should KnowMike Carruthers | OmniCast Media
Radiolab
RadiolabWNYC Studios
Hidden Brain
Hidden BrainHidden Brain, Shankar Vedantam
StarTalk Radio
StarTalk RadioNeil deGrasse Tyson
Science Friday
Science FridayScience Friday and WNYC Studios
Science Vs
Science VsSpotify Studios
Big Ideas Lab
Big Ideas LabMission.org

Talking Points

Recent interactions between the hosts and their guests.

S1 Ep205: Insights Across Hematologic Oncology at Columbia University
Q: How can markers such as CTDNA and MRD translate to actionable clinical strategies in the context of DLBCL and other lymphomas?
MRD and CTDNA testing could guide de-escalation or escalation of treatment during therapy, enable consolidation strategies after treatment, and potentially replace some imaging or invasive biopsies in surveillance, though prospective trials are needed to prove improved outcomes.
S1 Ep205: Insights Across Hematologic Oncology at Columbia University
Q: Don't forget to subscribe to the Oncology On The Go podcast on Apple Podcasts, Spotify, or anywhere podcasts are available, or listen online at cancernetwork.com/resources/podcasts.
This line is promotional rather than a substantive Q&A; no actionable answer beyond subscription encouragement.
S1 Ep205: Insights Across Hematologic Oncology at Columbia University
Q: How do you strike a balance between achieving activity and safety in novel therapies, especially among older patients with Hematologic Malignancies?
Older patients often have comorbidities, but newer oral targeted therapies tend to be better tolerated; selection should consider cardiac risk, renal function, and overall frailty, balancing efficacy with toxicity and potentially favoring time-limited regimens where appropriate.
S1 Ep204: Unraveling the Potential of Iberdomide and CELMoDs in Multiple Myeloma
Q: What should listeners take away from this conversation about the future of myeloma therapy?
The toolbox for myeloma is expanding; combining immune-modulating agents with other immunotherapies, while maintaining manageable toxicity, may bring us closer to durable remissions or cures, with patient-centric options like oral regimens playing a key role.
S1 Ep204: Unraveling the Potential of Iberdomide and CELMoDs in Multiple Myeloma
Q: Beyond this approval, what developments in multiple myeloma are you most excited about?
Moving cell mods into earlier lines of therapy, testing Iberdarmed combinations in frontline triplets or quadruplets, maintenance settings, and integrating them with emerging immune therapies to sustain immune activity and extend remissions.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About Oncology On The Go

What is Oncology On The Go about and what kind of topics does it cover?

This program features in-depth conversations with clinicians, researchers, and industry voices who discuss current oncologic and hematologic literature, treatment paradigms, and translational science. Episodes frequently cover newly approved therapies, practical adoption of treatments in real-world settings, biomarkers and diagnostics (MRD, ctDNA), and emerging modalities such as immunotherapies, CAR-T, and cell-modulating therapies. A notable strength is its multidisciplinary approach, combining clinical trial data, real-world experiences, and ethical considerations (such as AI in oncology and psychosocial care), with frequent emphasis on patient-centered decision making, access, and implementation challenges across care settings. The show... more

Where can I find podcast stats for Oncology On The Go?

Rephonic provides a wide range of podcast stats for Oncology On The Go. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Oncology On The Go and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does Oncology On The Go get?

Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Oncology On The Go, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for Oncology On The Go?

Rephonic provides comprehensive predictive audience data for Oncology On The Go, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does Oncology On The Go have?

To see how many followers or subscribers Oncology On The Go has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to Oncology On The Go?

These podcasts share a similar audience with Oncology On The Go:

1. Two Onc Docs
2. Oncology Today with Dr Neil Love
3. OncLive® On Air
4. ASCO Guidelines
5. Research To Practice | Oncology Videos

How many episodes of Oncology On The Go are there?

Oncology On The Go launched 6 years ago and published 233 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact Oncology On The Go?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for Oncology On The Go?

Rephonic pulls ratings and reviews for Oncology On The Go from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for Oncology On The Go?

Rephonic provides full transcripts for episodes of Oncology On The Go. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on Oncology On The Go?

Recent guests on Oncology On The Go include:

1. Dr. Julian Hong
2. Ilana Braun
3. Nicole Lamanna
4. Rajshekhar Chakraborty
5. Hua-Jay Jeff Cherng
6. Dr. Sagar Lonial
7. Daniel C. McFarland
8. Boris Kiselev

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days